stay tuned:
elixi news from the
world

We are a Swiss pharmaceutical wholesaler, specialized in sourcing and delivering pharma products, medical devices and drugs from and to all over the world.

Cyltezo(adalimumab-adbm), the First Interchangeable Biosimilar to Humira

3 Novembre 2021

The US FDA has approved the first interchangeable biosimilar product to treat certain inflammatory diseases. Cyltezo (adalimumab-adbm), originally approved in August 2017, is both biosimilar

[ More ]